Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis

American Journal of Pathology

Volumn 166, Issue 4, 2005, Pages 1017-1028

  Kim, Wook Hwan ^a,b   Matsumoto, Kunio ^a   Bessho, Kazuhiko ^a   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; DIMETHYLNITROSAMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; TARGET CELL;

EID: 17144366279     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62323-1     Document Type: Article

References (53)

1. Friedman SL: The cellular basis of hepatic fibrosis. N Engl J Med 1993, 328:1828-1835
2. Alcolado R, Arther MJP, Iredale JP: Pathogenesis of liver fibrosis. Clin Sci 1997, 92:103-112
3. Wu J, Zern MA: Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000, 35:665-672
4. Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, Ramadori G: Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999, 117:1205-1221
5. Bhunchet E, Wake K: Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis. Hepatology 1992, 16:1452-1473
6. Tuchweber B, Desmouliere A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabiani G: Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996, 74:265-278
7. Ramadori G, Saile B: Mesenchymal cells in the liver-one cell type or two? Liver 2002, 22:283-294
8. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Novell C, Arthur MJP: Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998, 102:538-549
9. Iredale JP: Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001, 21:427-436
10. Saile B, Knittel T, Matthes N, Schott P, Ramadori G: CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol 1997, 151:1265-1272
11. Saile B, Matthes N, Neubauer K, Eisenbach C, El-Armouche H, Dudas J, Ramadori G: Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-α. Am J Physiol 2002, 283:G435-G444
12. Nakamura T, Nawa K, Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984, 122:1450-1459
13. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443
14. Birchmeier C, Gherardi E: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998, 8:404-409
15. Matsumoto K, Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996, 119:591-600
16. Pepper MS, Matsumoto K, Nakamura T, Montesano R: Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and uPA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 1992, 267:20493-20496
17. Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC, Welgus HG: Mechanisms of hepatocyte growth factor-stimulation of keratinocyte metalloproteinase production. J Biol Chem 1996, 271:24567-24582
18. Dohi M, Hasegawa T, Yamamoto K, Marshall BC: Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis. Am J Respir Crit Care Med 2000, 162:2302-2307
19. Ozaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K: Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002, 36:169-178
20. Matsuda Y, Matsumoto K, Ichida T, Nakamura T: Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995, 118:643-649
21. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K: Anti-fibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996, 24:636-642
22. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997, 26:81-89
23. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999, 5:226-230
24. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K, Ishii T: The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 2000, 59:681-690
25. Seki T, Ihara I, Sugimura A, Shimonishi M, Nishizawa T, Asami O, Hagiya M, Nakamura T, Shimizu S: Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun 1990, 172:321-327
26. Knook DL. Seffelaar AM, de Leeuw AM: Fat-storing cells of the rat liver. Their isolation and purification. Exp Cell Res 1982, 139:468-471
27. Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H, Morinaga T: Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Biochem Biophys Res Commun 1990, 170:397-404
28. Tajima H, Matsumoto K, Nakamura T: Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett 1991, 291:229-232
29. Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV: Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992, 89:373-737
30. Conner EA, Wirth PJ, Kiss A, Santoni-Rugiu E, Thorgeirsson SS: Growth inhibition and induction of apoptosis by HGF in transformed rat liver epithelial cells. Biochem Biophys Res Commun 1997, 236:396-401
31. Arakaki N, Kazi JA, Kazihara T, Ohnishi T, Daikuhara Y: Hepatocyte growth factor/scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in sarcoma 180 cells. Biochem Biophys Res Commun 1998, 245:211-215
32. Conner EA, Teramoto T, Wirth PJ, Kiss A, Garfield S, Thorgeirsson SS: HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Carcinogenesis 1999, 20:583-590
33. Pinzani M: PDGF and signal transduction in hepatic stellate cells. Front Biosci 2002, 7:1720-1726
34. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, Gentilini P: Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 1999, 30:951-958
35. Ikura Y, Morimoto H, Ogami M, Jomura H, Ikeoka N, Sakurai M: Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol 1997, 32:496-501
36. Marra F, Valente AJ, Pinzani M, Abboud HE: Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology 1994, 107:1110-1117
37. Kinnman N, Francoz C, Barbu V, Rey C, Hultcranz R, Poupon R, Housset C: The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 2003, 83:163-173
38. Chen Z, Chua CC, Ho Y, Hamdy R, Chua BHL: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol 2001, 280:H2313-H2320
39. Crenesse C, Laurens M, Gugenheim J, Heurteaux C, Cursio R, Rossi B, Schmid-Alliana S: Intermittent ischemia reduces warm hypoxia-reoxygenation- induced JNK1/SAPK1 activation and apoptosis in rat hepatocytes. Hepatology 2001, 34:972-978
40. Gressner AM, Polzar B, Lahme B, Mannherz H-G: Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor-β. Hepatology 1996, 23:571-581
41. Shima N, Stolz DB, Miyazaki M, Gohda E, Higashio K, Michalopoulos GK: Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor. J Cell Physiol 1998, 177:130-136
42. Tsukada Y, Miyazawa K, Kitamura N: High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J Biol Chem 2001, 276:40968-40976
43. Dunn C, Wiltshire C, MacLaren A, Gillespie DA: Molecular mechanism and biological functions of c-Jun N-terminal kinase signaling via the c-Jun transcription factor. Cell Signal 2002, 14:585-593
44. Lin A: Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003, 25:17-24
45. Iwama A, Yamaguchi N, Suda T: STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J 1996, 15:5866-5875
46. Trim N, Morgan S, Evans M, Issa R, Fine D, Afford S, Wilkins B, Iredale J: Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol 2000, 156:1235-1243
47. Matsumoto K, Tajima H, Okazaki H, Nakamura T: Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemia cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem 1992, 267:24917-24120
48. Mizuno S, Kurosawa T, Matsumoto K, Horikawa Y, Okamoto M, Nakamura T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998, 101:1827-1834
49. Yang J, Dai C, Liu Y: Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 2001, 8:1470-1479
50. Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997, 156:1937-1944
51. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T: Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 2002, 40:47-53
52. Rojkind M, Dunn MA: Hepatic fibrosis. Gastroenterology 1979, 76:849-863
53. Hunt J: Long-term follow-up of patients with hepatitis B treated with interferon. Infections Cytokines 1992, 20:6-9